logo
#

Latest news with #Centrum

Volatility in global commodity prices amid ongoing geopolitical tensions can fuel inflationary pressures: Report
Volatility in global commodity prices amid ongoing geopolitical tensions can fuel inflationary pressures: Report

India Gazette

time13-06-2025

  • Business
  • India Gazette

Volatility in global commodity prices amid ongoing geopolitical tensions can fuel inflationary pressures: Report

New Delhi [India], June 13 (ANI): Volatile global commodity prices and ongoing geopolitical tensions could disrupt supply chains and fuel inflationary pressures impacting food prices, said a report by Centrum. Despite a positive outlook for food price stability supported by the India Meteorological Department's normal monsoon forecast, analysts at Centrum remain cautious of potential upside risks. 'We remain cautious of potential upside risks stemming from volatile global commodity prices and geopolitical tensions, which could disrupt supply chains,' the report added. The report added that regular monsoons will strengthen the case for ongoing low inflation in the near future. 'IMD's forecast of normal monsoon further supports the outlook for sustained food price stability and reinforces the case for continued low inflation in the near term,' the report added. In its latest policy rate announcement in the ongoing month, the RBI slashed repo rate by 50 basis point (bps), recording a total of 100 bps in the calendar year (CY) 2025 so far. The Central Bank shifts to a neutral stance highlight its growing comfort with the inflation trajectory and a renewed focus on supporting growth, while still acknowledging the global uncertainties. On the inflation front, the latest government data shows a declining retail inflation or CPI at 2.8 per cent in the month of May from its 3.2 per cent of April. This was mainly on account 64 bps drop in food and beverages (F&B) prices. Inflation in Food and Beverages, on YoY basis, slowed from 2.14 per cent to 1.5 per cent, which is the lowest print since May 2019. Vegetable prices continued to see contraction, recording a print of 13.7 per cent due to the seasonal effect and a higher base last year, with just 5 out of 21 sub-indices recording growth for the month. Among the leading basket items, onion prices saw a sharp contraction compared to April, was down by 10.7 per cent compared to positive 2.9 per cent QoQ and 40 per cent in May 2024. Inflation in potato deepened further by -20.3 per cent compared to -12.7 per cent and tomato prices continued its correction for the fifth month straight down 26.2% compared to -33 per cent in April. Inflation in Oils basket continued to be elevated, rising from 17.5 per cent to 18 per cent mainly due to higher customs duty to support domestic production, the sub-index recorded double digit price increase for seven straight months. The report expects inflation to average at 2.9 per cent in the first quarter of the fiscal year 2026, in line with the RBI's projection. (ANI)

Starlink to complement, not compete with Airtel & Jio says Centrum's report
Starlink to complement, not compete with Airtel & Jio says Centrum's report

India Gazette

time05-06-2025

  • Business
  • India Gazette

Starlink to complement, not compete with Airtel & Jio says Centrum's report

New Delhi [India], June 5 (ANI): According to the recent report by Centrum, it believes that SpaceX's satellite internet division, Starlink, is not positioned to compete directly with major telecom operators like Reliance Jio, Airtel, or VIL. The reports say that instead of this, Starlink is strategically positioned to complement India's existing connectivity landscape, specifically targeting remote and hard-to-reach areas where traditional network infrastructure is currently unviable. Starlink is preparing for its highly anticipated launch in India following conditional approvals from the Department of Telecommunications (DoT). This significant regulatory stride, marked by a Letter of Intent (LoI), enables Starlink to operate under stringent compliance and localisation mandates. Centrum says that this initial network capacity is estimated to serve approximately 50,000 users at launch. Even with projected improvements, a total bandwidth of 3 Tbps by 2027 will restrict usage to select high-need zones and high-tiered plans. Pricing is expected to be in a premium range, with a basic plan at around Rs850/month for 50GB and Rs2,500-Rs3,400/month for unlimited data. User equipment costs, ranging from Rs21,000 to Rs43,000, may pose challenges for adoption in rural areas without subsidies. Urban and metro areas are likely to see low uptake due to the availability of low-cost fibre broadband options. However, Starlink's presence is not expected to disrupt existing ISPs or mobile operators in the near term, but rather add value by addressing India's digital access gaps. Due to high terminal and plan costs, it is likely to remain a premium offering focused on specific use cases, rather than widespread consumer adoption. Long-term expansion and cost reductions, coupled with a favourable regulatory framework, could enable broader impact. The report also believes that as a strategic connectivity tool, Starlink could support national goals like Digital India and BharatNet, especially where fibre deployment is impractical. Recently, Minister for Communications Jyotiraditya Scindia said Elon Musk's Starlink will be the third satellite internet company to be given a license for providing services in India. (ANI)

Starlink to complement, not compete with Jio, Airtel, Vodafone Idea: Centrum Broking
Starlink to complement, not compete with Jio, Airtel, Vodafone Idea: Centrum Broking

Time of India

time05-06-2025

  • Business
  • Time of India

Starlink to complement, not compete with Jio, Airtel, Vodafone Idea: Centrum Broking

New Delhi: According to the recent report by Centrum, it believes that SpaceX's satellite internet division, Starlink , is not positioned to compete directly with major telecom operators like Reliance Jio , Airtel , or VIL. The reports say that instead of this, Starlink is strategically positioned to complement India's existing connectivity landscape, specifically targeting remote and hard-to-reach areas where traditional network infrastructure is currently unviable. Starlink is preparing for its highly anticipated launch in India following conditional approvals from the Department of Telecommunications (DoT). This significant regulatory stride, marked by a Letter of Intent (LoI), enables Starlink to operate under stringent compliance and localisation mandates. Centrum says that this initial network capacity is estimated to serve approximately 50,000 users at launch. Even with projected improvements, a total bandwidth of 3 Tbps by 2027 will restrict usage to select high-need zones and high-tiered plans. Pricing is expected to be in a premium range, with a basic plan at around Rs850/month for 50GB and Rs2,500-Rs3,400/month for unlimited data. User equipment costs, ranging from Rs21,000 to Rs43,000, may pose challenges for adoption in rural areas without subsidies. Urban and metro areas are likely to see low uptake due to the availability of low-cost fibre broadband options. However, Starlink's presence is not expected to disrupt existing ISPs or mobile operators in the near term, but rather add value by addressing India's digital access gaps. Due to high terminal and plan costs, it is likely to remain a premium offering focused on specific use cases, rather than widespread consumer adoption. Long-term expansion and cost reductions, coupled with a favourable regulatory framework, could enable broader impact. The report also believes that as a strategic connectivity tool, Starlink could support national goals like Digital India and BharatNet, especially where fibre deployment is impractical. Recently, Minister for Communications Jyotiraditya Scindia said Elon Musk's Starlink will be the third satellite internet company to be given a license for providing services in India.

Anushka Sharma On Wellness, Energy And The Simple Secrets Behind Her Daily Glow
Anushka Sharma On Wellness, Energy And The Simple Secrets Behind Her Daily Glow

News18

time26-05-2025

  • Entertainment
  • News18

Anushka Sharma On Wellness, Energy And The Simple Secrets Behind Her Daily Glow

Last Updated: Anushka Sharma shares how consistent routines, clean eating, and daily movement keep her energized and glowing—inside and out Actor, producer, mother, and wellness enthusiast—Anushka Sharma juggles many roles with grace. Her active lifestyle and commitment to fitness are often lauded, but behind the glow and energy lies a philosophy rooted in balance, discipline, and self-care. In an exclusive interaction, Anushka opens up about her approach to health, how she stays energized amid her packed schedule, and her summer wellness rituals. Health, Beyond the Surface 'For me, health is about feeling good from the inside out," Anushka says. 'It's about having the energy to pursue my passions, be present with my family, and take care of myself. It's not just about physical appearance, but about overall well-being." Her Wellness Rituals Daily rituals play a crucial role in Anushka's routine. 'I try to start my day with some form of movement, whether it's yoga, a walk, or a workout. I also prioritize getting enough sleep, staying hydrated, and eating a balanced diet with a healthy mix of multivitamins to support my diet. I am a stickler for routine for both myself and family, and mealtimes are always at the same time." Energy Management in a Hectic Lifestyle With work, travel, and motherhood all demanding her attention, how does Anushka keep her energy intact? 'It's definitely a challenge sometimes, but we lead a very active lifestyle with lots of outdoor sports, physical activities, etc. Maintaining consistency is key as it helps build one's strength and stamina. One thing about energy is that our body keeps on losing energy with all daily activities, and one needs to keep replenishing it," she explains. 'Whether it's after a morning workout or after a good fitness session, or even after a long day at work, it's important to keep yourself energized and hydrated. Talking about energy—I have been associated with Centrum for quite some time now and recently they have launched Centrum Recharge, which is a tasty effervescent energy drink mix loaded with 13 vitamins & minerals to support Energy, Immunity & Hydration. Lastly, sleep too is very important in maintaining energy—we always have an early dinner and sleep early to keep our metabolism in place." The Source of Her Glow 'I think it's a combination of things. Of course, taking care of my physical health is important—eating nutritious foods, staying hydrated, and getting enough sleep, as much as possible. And of course, as I mentioned, Centrum plays a key role in filling any nutritional gaps and making sure I'm feeling my best from the inside out." Putting Self-Care First Even amid the whirlwind of her day, Anushka makes time for herself. 'Self-care for me means carving out time for yoga or a brisk walk to stay active and clear my mind. I also focus on eating balanced, home-cooked meals and taking my daily multivitamins to fill nutritional gaps. This routine keeps me energized throughout the day." Her Summer Wellness Playbook As someone who adapts her wellness practices with the seasons, summer comes with its own rhythm. 'In summer, I focus on foods like salads and smoothies to stay nourished and beat the heat. Since the day gets too hot, I try to take early morning walks and maintain consistent hydration throughout the day to ensure I don't lose out on energy."

Pfizer share climbs 11% post healthy Q4; announces Rs 165 dividend for FY25
Pfizer share climbs 11% post healthy Q4; announces Rs 165 dividend for FY25

Business Standard

time20-05-2025

  • Business
  • Business Standard

Pfizer share climbs 11% post healthy Q4; announces Rs 165 dividend for FY25

Pfizer shares climbed after the company reported a strong set of March quarter results on May 19, 2025. SI Reporter New Delhi Pfizer share price: Shares of Pfizer were in demand on Tuesday, May 20, 2025, with the scrip rallying up to 11.33 per cent to an intraday high of ₹4,970.40 per share. What is the reason behind the rally in Pfizer share price? Pfizer shares climbed after the company reported a strong set of March quarter results on May 19, 2025. The company's profit soared 85 per cent year-on-year (Y-o-Y) to ₹331 crore in the March quarter of FY25, from ₹179 crore in the March quarter of FY24. Pfizer's revenue from operations rose 8.3 per cent Y-o-Y to ₹591.9 crore in Q4FY25, from ₹546.6 crore in Q4FY24. At the operating level, earnings before interest, tax, depreciation and amortisation (Ebitda) climbed 20.1 per cent annually to ₹227.5 crore in March quarter of FY25, from ₹189.43 crore in the March quarter of FY24. Pfizer dividend The Board of Directors has recommended a final dividend of ₹35 per equity share of ₹10 each (350 per cent) and a special dividend of ₹100 per equity share of ₹10 each (1000 per cent) in view of 75th year of Pfizer in India and a special dividend of ₹30 per equity share of ₹10 each (300 per cent) in view of the gain on transfer of assignment of leasehold land and building constructed on such land thereon, totaling to a dividend of ₹165 per equity share ₹10 each (1650 per cent) for FY25. Moreover, the company has fixed July 9, 2025, as the Record Date for determining entitlement of Members to final dividend for the financial year ended March 31, 2025. About Pfizer Pfizer is a globally recognised biopharmaceutical company with a legacy spanning more than 170 years. Headquartered in New York City, the company is dedicated to discovering, developing, and delivering medical breakthroughs that improve lives. With operations in over 125 countries, Pfizer plays a critical role in advancing global health through a diverse range of innovative treatments and vaccines. In India, Pfizer has a strong presence, including a state-of-the-art manufacturing facility in Goa that supports both local and international supply chains. ALSO READ | The company's work spans key therapeutic areas such as vaccines, oncology, internal medicine, and rare diseases. Pfizer is a leader in vaccine development, notably using mRNA technology in its COVID-19 vaccine. Its oncology division focuses on cutting-edge cancer treatments, while internal medicine offerings address chronic conditions like diabetes and heart disease. Pfizer also invests in rare disease research and provides popular over-the-counter products like Advil, Nexium, Centrum, and ChapStick.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store